BioXcel is a pioneer in cloud based pharma big data analytics solutions for Healthcare. Our proprietary Big Data Innovation Lab facilitates the design, discovery, development and commercialization of new disease treatments across multiple therapeutic areas.
http://www.bioxcel.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Thursday
LOAD TIME
4.9 seconds
16x16
32x32
64x64
128x128
PERFECT PRIVACY, LLC
12808 Gra●●●●●●●●●kway West
Jack●●●●ille , FL, 32258
UNITED STATES
View this contact
PERFECT PRIVACY, LLC
12808 Gra●●●●●●●●●kway West
Jack●●●●ille , FL, 32258
UNITED STATES
View this contact
PERFECT PRIVACY, LLC
12808 Gra●●●●●●●●●kway West
Jack●●●●ille , FL, 32258
UNITED STATES
View this contact
BUY YOUR DOMAIN
20
YEARS
3
MONTHS
3
DAYS
NETWORK SOLUTIONS, LLC.
WHOIS : whois.networksolutions.com
REFERRED : http://networksolutions.com
PAGES IN
THIS WEBSITE
18
SSL
EXTERNAL LINKS
14
SITE IP
50.62.30.145
LOAD TIME
4.89 sec
SCORE
6.2
Bioxcel | Home | bioxcel.com Reviews
https://bioxcel.com
BioXcel is a pioneer in cloud based pharma big data analytics solutions for Healthcare. Our proprietary Big Data Innovation Lab facilitates the design, discovery, development and commercialization of new disease treatments across multiple therapeutic areas.
bioxcel.com
SERVICE CAPABILITIES - Bioxcel
http://bioxcel.com/service-capabilities
Oncology & Immuno-Oncology. Repurposing & Reformulation. Events & Marketing Activities. A pathway to the future which identifies a strategic, corporate and disease area roadmap that navigates the existing market landscape and shapes how businesses at various stages from R&D to commercialization must adapt to the unique requirements of the healthcare ecosystem. Build a Robust Strategy -. Impact of Evolving Healthcare. Modality Change New Entrants such as biosimilars. Disruptive Innovation Big Data. Foreca...
News Archives - Bioxcel
http://bioxcel.com/category/media/inthenews
Oncology & Immuno-Oncology. Repurposing & Reformulation. Events & Marketing Activities. Cellular Horizons Third International Conference - A New Paradigm in Drug Discovery and Health Care Delivery, Dr. Krishnan Nandabalan, Ph.D., President and CSO, Panel Member. Krishnan Nandabalan, President and CSO Discusses the Practical Side of Lab Research. Silicon India recognises pharma and life sciences solution providers. Cancer Research May Benefit from Big Data Immuno-Oncology Platform. 780 East Main Street.
Resources - Bioxcel
http://bioxcel.com/resources
Oncology & Immuno-Oncology. Repurposing & Reformulation. Events & Marketing Activities. Events and marketing activities. BMS’s Opdivo Placed in a Hotspot Over Latest Clinical Results. Is There Light at the End of the Tunnel? Your Latest Edition of PharmGPS Insights is Here. A 60yr Wait for Benlysta but GSK is About to Feel the Heat! From Doomed to Deemed: Brodalumab Continues Its Long Fateful Journey. PEGylated Interleukin-10: A New Approach to Promote Anti-Tumor Immunity. Page 1 of 7. Branford, CT 06405.
Orphan Diseases | Pharm GPS TM Orphan Disease Suite | Bioxcel
http://bioxcel.com/orphan-disease
Oncology & Immuno-Oncology. Repurposing & Reformulation. Events & Marketing Activities. Majority of the 7000 rare and ultra rare diseases are genetic in origin and lack a FDA approved medication. Further, the scant and disparate nature of associated data adds to the complexity and challenge of designing safe and efficacious therapies. Attractive orphan disease-target identification. Validated by pre-clinical program initiation. Attractive Gene Therapy-Orphan Disease Space. See how you can leverage the.
Pharmaceutical R&D - Integrating Specific Analyses of Medical, Scientific and Health Economic Data
http://bioxcel.com/mta
Oncology & Immuno-Oncology. Repurposing & Reformulation. Events & Marketing Activities. Major Therapeutic Areas Suite. An aging population and increasing healthcare costs have crystallized the need for safe, efficacious and cost-effective medicines for treating chronic and acute diseases across major therapeutic areas. The challenges here include assessing the efficacy of the new medications in preventing deterioration of a disease and in a best case scenario, actually curing the disease. PharmGPS.
TOTAL PAGES IN THIS WEBSITE
18
Interview with David Hall : Phacilitate
http://www.phacilitate.co.uk/news/interview-with-david-hall
Interview with David Hall. Interview with David Hall. Phacilitate: Please can you outline Replicel’s two autologous cell therapy technology platforms for us? Phacilitate: Okay, what are your goals and priorities for progressing Replicel’s R&D pipeline through 2015? We also have a goal to do the geographic [licence 0:03:23] for our NBDS fibreglass platform, geographic licence in Asia, in particular focused on Japan, and we will begin discussions around the generation two licence. Our final goal essent...
Register Your Interest : Phacilitate
http://www.phacilitate.co.uk/cell-and-gene-therapy-europe-enquiry
Please fill in the form below to register your interest in Cell and Gene Therapy Europe 2015. Give us your input on specific topics and speakers of interest to you - talk to a Phacilitate member of staff onsite, or email team@phacilitate.co.uk . The Most Influential Women in Cell and Gene Therapy. Ross Macdonald @ RossTheMac. Stefanos Theoharis, Walter Brooks &many more! Latest confirmed speakers for Phacilitate Leaders Europe are online. Join our upcoming webinar about # immunotherapy.
Interview with Perry Karsen : Phacilitate
http://www.phacilitate.co.uk/news/interview-with-perry-karsen
Interview with Perry Karsen. Interview with Perry Karsen. Phacilitate: Celgene were one of the first major biopharma companies to actively engage and invest in the cell therapy space how do you reflect on the development of the sector over the past decade? How has the Cellular Therapeutics area evolved in terms of its status and importance within the business model of Celgene Corporation as a whole over this period? Patients. If we are able to do this, the access will come and that is the critical fa...
Interview with Mark Trusheim : Phacilitate
http://www.phacilitate.co.uk/news/interview-with-mark-trusheim
Interview with Mark Trusheim. Interview with Mark Trusheim. Phacilitate: Your research at MIT focuses on the economics of stratified medicine. You have been involved in a variety of functional and technology areas and in a number of sectors through the course of your career. Can you reflect on how you came to be involved in this particular field of research? Finally, I actually began my career in High Tech, doing Big Data systems back in the days before we knew to call them Big Data systems! Phacilitate:...
Site map : Phacilitate
http://www.phacilitate.co.uk/site-map
Cell and Gene Therapy Europe 2016. Big Data in Precision Medicine. The Most Influential Women in Cell and Gene Therapy. Opinion Piece by Nigel Hughes. Inside scoop on ASCO's CancerLinQ. Text analytics for your IDMP compliance journey. Dr Richard L. Schilsky. Dr Jan Lundberg, Ph.D. Michel Sadelain, MD, PhD. Bradford R. Hirsch, MD, MBA. Phacilitate are recruiting. Come and join us! Dr Art Krieg,. Taylor Schreiber, M.D. Ph.D. Dr Paula Salmikangas Interview. Dr Maria Christina Galli. Interview with David Hall.
News : Phacilitate
http://www.phacilitate.co.uk/news
The Most Influential Women in Cell and Gene Therapy. The cell and gene therapy industry is currently expanding rapidly and recruitment is becoming more of a focus for organizations, however despite expansion there is still a lack of diversity running throughout the sector. Interview with Dr Mark Roberts, Analytics Consultant, Tessella. Opinion Piece by Nigel Hughes. Inside scoop on ASCO's CancerLinQ. Join our upcoming webinar about # immunotherapy. Https:/ t.co/iwMjOYjNA7 # poken. After many successful P...
About Us : Phacilitate
http://www.phacilitate.co.uk/about-us
Phacilitate is a specialist in the organisation of exclusive events for leaders from the pharma, biotech and bigdata communities. Our philosophy is simple - to deliver the ultimate in strategic knowledge exchange and networking through flawless, personalised service. Our team is focused on conferences each year:. Cell and Gene Therapy World. 25-27 January 2016 Washington). 25-27 January 2016 Washington). 5-6 April 2016 Boston). Big Data Leaders Europe. 23-24 May 2016 London). Cell and Gene Therapy Europe.
Forthcoming Phacilitate Events : Phacilitate
http://www.phacilitate.co.uk/events
Cell and Gene Therapy. 21-22 September Maritim proArte Hotel Berlin. 21-22 September 2016 Maritim proArte Hotel Berlin. Phacilitate are launching Immunotherapy Europe in Berlin in September 2016 alongside Cell and Gene Therapy Europe. Immuno-oncology is the hot topic across the life science sector following a slew of recent successes and approvals. Meet leaders from across the sector to discover the path to commercialization in Europe. Be part of this exciting new event from the start! The cell and gene ...
TOTAL LINKS TO THIS WEBSITE
14
BioXavi1 (Evan Patterson) - DeviantArt
Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) " class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 10 Years. This deviant's full pageview. Last Visit: 133 weeks ago. This is the place where you can personalize your profile! By moving, adding and personalizing widgets. Why," you ask? Carey still ...
bio
Colograder / DI manager at Caviarcontent. Features, documentary and short films. Da Vinci Resolve( in production) / Assimilate Scratch(in production) / Baselight. English: good knowledge spoken and written. Dutch: knowledge, good understading. Inscription à : Articles (Atom). Afficher mon profil complet. Freelance Colorgrader 2012-Present Colograder / DI. Modèle Simple. Fourni par Blogger.
BioxBio
9658; International Journal for Equity in Health. 9658; ACS Macro Letters. 9658; Journal of Veterinary Behavior-Clinical Applications and Research. 9658; Journal of Public Relations Research. 9658; Journal Of Cerebral Blood Flow And Metabolism. 9658; American Journal Of Clinical Hypnosis. 9658; Journal Of Electron Spectroscopy And Related Phenomena. 9658; World Bank Economic Review. 9658; Discrete Event Dynamic Systems-Theory And Applications. 9658; Current Opinion In Rheumatology.
Biox – Pecuária Moderna
A Biox desde que foi criada em 2004, vem se destacando como uma empresa inovadora, oferecendo serviços e tecnologias de qualidade para a pecuária de corte, atualmente, atende o pecuarista com os serviços de Certificação SISBOV, Consultoria Pecuária e Aplicativos para a pecuária. Confira nossas empresa logo abaixo:. A metodologia de trabalho da Biox Consultoria atende de forma sistêmica todos os setores da fazenda de gado de corte, seja de cria, recria e engorda ou ciclo completo. Adota, dentre outras...
Bioxcel | Home
BioXcel is applying AI and Big data technologies to power the next wave of medicines. We are a biopharmaceutical company pioneering the application of artificial intelligence and big data analytics integrated with drug development expertise. We use our proprietary platforms to advance the next wave of medicines and significantly improve the clinical and regulatory success of drug development. Is a SAAS platform that is used to project the future performance trajectories of drugs in development. For Resea...
BioX blog
Our methodology is the result of breakthrough research into bioprocess optimization funded through the US Department of Defense. . We offer customers two payment options. The first is a traditional upfront fee for services. Or an option that makes meaningful. For bio-product companies, we deliver advanced technology to optimize today's advanced bioprocesses. 21st Century Optimization Technology. Illustrating application of our technology over a very diverse set of bioprocess applications. See What We Do.
Biopharmaceutical Contract Manufacturer | BioXcellence International
Manufacturing Process at a Glance. Media Design and Optimization. Manufacturing Science and Technology. Press Releases and Media. Read more about Fill and Finish". The entire biopharmaceutical contract manufacturing chain under one roof. Read more about Fill and Finish. Read more about cGMP". Quality under late stage cGMP. Read more about cGMP. Read more about our Track Record". Experience as one of the longest running and most reliable contract manufacturing organizations in the world. The entire produc...
BioXcell Life Sciences
Life Sciences Pvt. Ltd. Products and Services we offers. Algal Bloom Control Probiotic. Growth Promoter for Shrimp. Probiotic for Soft Shell or Loose Shell for Shrimp. Soil and Water Probiotics. Anti Lice for Fish. BioXcell objective is excellent healthcare through Biotechnology with research and development of pre-and probiotics along with APIs in pellets forms such as EC, TR, SR, CR and TM Pellets for better patient dosage compliance. read more.
Welcome to BIOXCESS - Everyone Has An Unique Identity
FAIL (the browser should render some flash content, not this).
Welcome @ INCA - Ihre Fullservice Internet Agentur
Sie verwenden einen Browser der keine Frames untersützt,. Dh Sie haben 4 Jahre Entwicklung versäumt. INCA Handl and Eckler OEG. 1030, Landstr. Haupstr. 146/7A/B1. Tel : 43 / 1 / 718 51 24. Fax : 43 / 1 / 718 51 24 / 31. E-mail : office@inca.at. Welcome @ INCA - Ihre Fullservice Internet Agentur. INCA - Projekt Maric and Rinaldin. Erich ZIB - Gästebuch. INCA - Projekt JobAward - Wiener ArbeitnehmerInnen Förderungsfonds - WAFF. INCA - Gewinnen Sie mit uns. INCA - Kontaktieren Sie uns. INCA - Die Ziele.
SOCIAL ENGAGEMENT